BioMarin Pharmaceutical | BMRN - 流动负债

金融业

USD

USD 8.59B

现金及等价物

USD 2.22B

USD 199.48M

USD 4.61B

USD 793.15M

USD 1.44B

USD 129.65M

USD 146.05M

3.04K

EPS每股收益

USD 0.76

股本和储备

USD 6.21B

USD 571.21M

债务利息支出

USD 14.96M

USD 22.56M

USD 1.43B

USD 11.53B

USD 105.53M

USD 636.56M

USD 129.65M

普通股股本

USD 193.27M

15.28

USD 141.2M

USD 766M

销售和管理费用

USD 258.28M

USD 1.27B

贸易债权人

USD 793.15M

应收帐款人

USD 903.91M

	流动负债	更改		日
Acadia Pharmaceuticals	USD 305.52M		28.41M	2026-03
Agios Pharmaceuticals	USD 58.84M		23.36M	2026-03
Alnylam Pharmaceuticals	USD 1.35B		116.87M	2026-03
Amgen	USD 24.96B		534M	2026-03
Bayer	EUR 33.46B		875M	2026-03
Biogen	USD 3B		350.5M	2026-03
BioMarin Pharmaceutical	USD 793.15M		34.12M	2026-03
Gilead Sciences	USD 9.48B		2.34B	2026-03
Incyte	USD 1.49B		25.52M	2026-03
Insmed	USD 361.01M		107.87M	2026-03
Ionis Pharmaceuticals	USD 717M		66M	2026-03
Moderna	USD 2.4B		408M	2026-03
Neurocrine Biosciences	USD 831.7M		88.3M	2026-03
PTC Therapeutics	USD 923.6M		44.82M	2026-03
Puma Biotechnology	USD 82.73M		3.63M	2025-09
Regeneron Pharmaceuticals	USD 5.11B		739.3M	2026-03
Roche Holding	CHF 28B		421M	2025-12
Sangamo BioSciences	USD 47.66M		1.9M	2025-06
Sanofi	EUR 30.01B		1.66B	2026-03
Sarepta Therapeutics	USD 499.16M		596.13M	2026-03
Ultragenyx Pharmaceutical	USD 325M		59M	2026-03
United Therapeutics	USD 599.1M		38.5M	2026-03
Vertex Pharmaceuticals	USD 3.88B		19.4M	2026-03